A phase II trial of the proteosome inhibitor PS-341 (Bortezomib; Velcade)in patients with metastatic colorectal cancer. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Mackay, HJ
  • Major, Pierre
  • Townsley, C
  • Mackenzie, M
  • Vincent, M
  • Boudreau, T
  • Tsao, M
  • Hedley, D
  • Wright, J
  • Siu, L
  • Moore, M
  • Oza, AM

publication date

  • December 1, 2003